Trademark Alertz ®
Search
Trademark
Owner
Trademark: XAAV 2276989
Word
XAAV
ID
2276989
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
28 February 2022
Registration Date
28 February 2022
Renewal Date
28 February 2032
Owner(s)
Oxford Genetics Ltd
Service
Goods and Services:
Class 1
:
Chemical and biological substances for use in science and industry
;
nucleic acids
;
nucleic recombinant acids, synthetic deoxyribonucleic acids
;
chemical and biological reagents for non-medical purposes
;
chemical and biological reagents for scientific and research purposes
;
human and animal cells and parts thereof for non-medical purposes
;
microorganisms for non-medical purposes
;
human and animal cells and parts thereof for scientific and research purposes
;
microorganisms for scientific and research purposes
;
viral vectors for use in science and industry
;
adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for scientific and research purposes
;
none of the aforesaid being or including cell growth media.
Class 5
:
Chemical and biological reagents for medical and veterinary use
;
diagnostic and test reagents for medical and veterinary use
;
human and animal cells and parts thereof for medical and veterinary purposes
;
microorganisms for medical and veterinary purposes
;
viral vectors for medical and veterinary purposes
;
adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for medical and veterinary use
;
none of the aforesaid being or including cell growth media.
Class 42
:
Design services relating to the creation and alteration of chemical and biological reagents
;
design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids
;
design services relating to the creation and alteration of recombinant viruses
;
design services relating to the creation and alteration of adeno-associated viruses (AAVs), AAV particles and AAV plasmids
;
research, development and bioengineering services relating to adeno-associated viruses (AAVs)
;
drug discovery services
;
design services relating to the creation and alteration of cell lines, elementary cells and parts thereof
;
design services relating to the creation and alteration of viral vectors
;
information and advice relating to all the aforesaid services
;
none of the aforesaid services relating to cell growth media.